Alto Neuroscience, Inc. (ANRO) stock
ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
$29.54−1.08 (-3.53%)
Close on Nov 13, 2026Market cap $1.16BP/E –Yield –
Alto Neuroscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alto Neuroscience's enterprise value was $865.63M on Nov 11, 2026, against $258.28M a year earlier. Over the last 3 years it ranged from -$100.18M to $1.01B, with a median of $124.75M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $865.63M | +136.8% |
| 2025 | Dec 31, 2025 | $365.59M | – |
| 2024 | Dec 31, 2024 | -$57.97M | – |
See a number that looks wrong?